Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Study of phosphorylation events for cancer diagnoses and treatment.

López Villar E, Madero L, A López-Pascual J, C Cho W.

Clin Transl Med. 2015 Dec;4(1):59. doi: 10.1186/s40169-015-0059-0. Epub 2015 May 24.

2.

A proteomic approach to obesity and type 2 diabetes.

López-Villar E, Martos-Moreno GÁ, Chowen JA, Okada S, Kopchick JJ, Argente J.

J Cell Mol Med. 2015 Jul;19(7):1455-70. doi: 10.1111/jcmm.12600. Epub 2015 May 9. Review.

3.

The human proteome organization (HUPO) and environmental health.

Merrick BA.

EHP Toxicogenomics. 2003 Jan;111(1T):1-5.

PMID:
12735104
4.

Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycle.

Tenga MJ, Lazar IM.

BMC Cancer. 2014 Sep 24;14:710. doi: 10.1186/1471-2407-14-710.

5.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
6.

Protein kinase signaling networks in cancer.

Brognard J, Hunter T.

Curr Opin Genet Dev. 2011 Feb;21(1):4-11. doi: 10.1016/j.gde.2010.10.012. Epub 2010 Nov 29. Review.

7.

Proteomic approaches in brain research and neuropharmacology.

Vercauteren FG, Bergeron JJ, Vandesande F, Arckens L, Quirion R.

Eur J Pharmacol. 2004 Oct 1;500(1-3):385-98. Review.

PMID:
15464047
8.

Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification.

Tang Y, Mackey J, Lai R, Ghosh S, Santos C, Graham K, Damaraju S, Pasdar M, Li L.

J Proteomics. 2013 Oct 8;91:200-9. doi: 10.1016/j.jprot.2013.06.034. Epub 2013 Jul 11.

PMID:
23851309
9.

Meeting report on the 7th World Congress of the Human Proteome Organization (HUPO) in Amsterdam: Proteome Biology.

Gavin AC, Aebersold R, Heck AJ.

Mol Cell Proteomics. 2008 Nov;7(11):2288-91. doi: 10.1074/mcp.H800011-MCP200.

10.

The strategy, organization, and progress of the HUPO Human Proteome Project.

Omenn GS.

J Proteomics. 2014 Apr 4;100:3-7. doi: 10.1016/j.jprot.2013.10.012. Epub 2013 Oct 19.

11.

The cancer proteomic landscape and the HUPO Cancer Proteome Project.

Jimenez CR, Zhang H, Kinsinger CR, Nice EC.

Clin Proteomics. 2018 Jan 25;15:4. doi: 10.1186/s12014-018-9180-6. eCollection 2018.

12.
13.

New cancer biomarkers deriving from NCI early detection research.

Verma M, Srivastava S.

Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.

PMID:
12903844
14.

Proteogenomic convergence for understanding cancer pathways and networks.

Boja ES, Rodriguez H.

Clin Proteomics. 2014 Jun 1;11(1):22. doi: 10.1186/1559-0275-11-22. eCollection 2014. Review.

15.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

16.

Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Leth-Larsen R, Lund RR, Ditzel HJ.

Mol Cell Proteomics. 2010 Jul;9(7):1369-82. doi: 10.1074/mcp.R900006-MCP200. Epub 2010 Apr 8. Review.

17.

Recent advances in proteomics: towards the human proteome.

Wang K, Huang C, Nice E.

Biomed Chromatogr. 2014 Jun;28(6):848-57. doi: 10.1002/bmc.3157. Review.

PMID:
24861753
18.

Nanotechnology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.

20.

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Shukla HD, Mahmood J, Vujaskovic Z.

Cancer Lett. 2015 Dec 1;369(1):28-36. doi: 10.1016/j.canlet.2015.08.003. Epub 2015 Aug 11. Review.

PMID:
26276717

Supplemental Content

Support Center